info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Needle Free Injection Market Research Report information By Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals)- Forecast Till 2032


ID: MRFR/HC/4721-CR | 100 Pages | Author: Kinjoll Dey| June 2018


Global Needle-Free Injection Market Overview


Needle Free Injection Market Size was valued at USD 0.17 Billion in 2023. The Global Needle Free Injection industry is projected to grow from USD 0.20 Billion in 2024 to USD 0.78 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 16.17% during the forecast period (2024 - 2032). Humans have traditionally received drugs via needles and injections. However, needle-free injection technology (NFIT), a revolutionary concept that encompasses a wide range of medication delivery devices, has just hit the market. 


Needle Free Injection Market


In June 2023, Prejex Inc., a subsidiary of Prejex GMBH headquartered in Germany, declared that it had entered into a manufacturing deal with Polybond for the production of needleless injections. This partnership has enabled the German company to move its manufacturing operations from Berlin to Pune, with the aim of enhancing global distribution. The Prejex-Polybond plant was said to be capable of manufacturing needleless injections for the entire world. The needle-free injection-based New Drug Delivery System (NDDS) developed by Prejex is a highly anticipated and groundbreaking invention in the medical field. 


In September 2023, Scancell, a collaborative venture of PharmaJet®, achieved positive outcomes in the first stage of its Phase 2 clinical trial focused on patients with unresectable advanced melanoma. Scancell specializes in developing precise delivery systems to overcome the challenges of administering pharmaceuticals and vaccines. 


Needle-Free Injection Market Trends


The rising number of diabetes patients throughout the world has generated a need for self-injection systems, which can easily be satisfied by needle-free injection systems; as a result, the market's growth is being propelled by the rising demand for self-medication. In addition, the frequency of chronic illnesses and the use of injectable drugs for therapy are driving up the demand for needle-free injection methods. Injectable drug delivery methods provide several benefits over oral drug delivery systems, including a faster start of the action and maximal bioavailability, making them suitable for use in emergency settings.



Needle-Free Injection Market Segment Insights


Needle-Free Injection Product Type Insights


By product type, the needle free injection market has been segmented into prefilled and fillable needle free injectors. By technology, the needle free injection market is segmented into laser-powered, spring-based, and jet-based. By usability, the market is segmented into disposable and reusable needle free injectors.  


Needle-Free Injection Medication Type Insights


By medication type, the needle free injection market is segmented into projectile/depot-based, powder-based, and liquid-based Suture needle free injectors. By site of delivery, intradermal, intramuscular, and subcutaneous are segments in the market. Oncology, vaccination, insulin delivery, and others are major market applications. Prime end-users include ambulatory surgical centers, homecare settings, hospitals and clinics, and others.


Needle-Free Injection Regional Insights


The segments and sub-segments covered in the report are analyzed under four major regions –Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. For the scope of research, the standard definition of the product/ service “needle free injection” is included in the report. The report discusses and interprets the current and future opportunities of the industry delivering an unbiased growth assessment.


Key Players Covered



  • CROSSJECT

  • Medical International Technology, Inc.

  • National Medical Products Inc.

  • INJEX Pharma GmBH

  • PenJet Corporation

  • Valeritas Holdings, Inc.

  • Antares Pharma Inc.

  • D'Antonio Consultants International, Inc.

  • MIKA MEDICAL CO.

  • PharmaJet, Inc.

  • Endo Pharmaceuticals Inc

  • Inovio Pharmaceuticals Inc.

  • European Pharma Group


The report offers comprehensive profiles on these market players and assesses their current standing in the needle free injection market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, M&A activities, and latest R&D initiatives are outlined in the report.


Research Methodology


Market Research Future (MRFR) uses a combination of primary and secondary research to compile market reports. Primary data is accumulated from interviewing industry stalwarts and secondary research is collated by studying white papers and annual reports of leading players. Our analysts use top-down and bottom-up approaches to validate the findings of the report. The report comprises news, current trends, and future prospects related to the market, all of which can provide a thorough understanding of the market to clients. Industry leaders can make accurate business decisions based on our insights.



Recent Development


The pharmaceutical business as we know it originated in Europe. It also houses the world's oldest and still functioning pharmaceutical firm, Merck KGaA, often known as the Merck Group in the United States, which marked its 350th anniversary in 2018. Europe and the United States continue to be the world's largest and most influential pharmaceutical markets. It's no surprise that the first widely authorized and used COVID-19 vaccine came from a joint venture between BioNTech in Germany and Pfizer in the United States.


Medical International Technology, Inc. is a company that manufactures, markets, and sells needle-free jet injector solutions for single and mass injections in people and animals. In the sphere of medical equipment, the company focuses on the medical and paramedical sectors The company's product lines include a home use injector for diabetics and other therapies that require daily injections, as well as a vaccine and other biological injectable medicines targeting physicians in their clinics.


Needle-Free Injection Market Segmentation



Needle-Free Injection Product Type Outlook



  • Prefilled Needle Free Injectors

  • Fillable Needle Free Injectors


Needle-Free Injection Technology Outlook



  • Laser-powered

  • Spring-based

  • Jet-based


Needle-Free Injection Usability Outlook



  • Disposable Needle Free Injectors

  • Reusable Needle Free Injectors


Needle-Free Injection Type of Medication Outlook



  • Liquid-based Needle Free Injectors

  • Powder-based Needle Free Injectors

  • Projectile/Depot-based Needle Free Injectors


Needle-Free Injection Site of Delivery Outlook



  • Intradermal Injectors

  • Intramuscular Injectors

  • Subcutaneous Injectors


Needle-Free Injection Application Outlook



  • Oncology

  • Vaccination

  • Insulin Delivery

  • Others


Needle-Free Injection End-user Outlook



  • Ambulatory Surgical Centers

  • Hospitals & Clinics

  • Homecare Settings

  • Others


Needle-Free Injection Regional Outlook



  • Americas; North America and South America

  • Europe; Western Europe and Eastern Europe

  • Asia Pacific (APAC); Japan, China, India, South Korea, and Rest of Asia Pacific

  • Middle East & Africa (MEA); The Middle East and Africa




Report Overview



This report allows the user to gain a deeper understanding of the ongoing events and trends in the needle free injection market. By correlating the historical data with key market dynamics, our analysts were able to make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the global needle free injection market segmented by product type, test type, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will also come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the needle free injection market during the assessment period.


Intended Audience



  • Government Research Institutes

  • Research and Development (R&D) Companies

  • Medical Devices Companies

  • Academic Institutes and Universities


Report Attribute/Metric Details
Market Size USD 0.78 Billion
Compound Annual Growth Rate (CAGR) 16.17% (2024-2032)
Base Year 2023
Market Forecast Period 2024-2032
Historical Data 2018 & 2020
Market Forecast Units Value (USD million)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Technology, Usability, Type of Medication, End User
Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled CROSSJECT, Medical International Technology, Inc., National Medical Products Inc., INJEX Pharma GmBH, PenJet Corporation, Valeritas Holdings, Inc., Antares Pharma Inc., D'Antonio Consultants International, Inc., MIKA MEDICAL CO., PharmaJet, Inc., Endo Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., and European Pharma Group
Key Market Opportunities Prevalence of various chronic diseases
Key Market Drivers Rise in investments in the pharmaceutical sector and convenient use of these medical devices in home care
 

Frequently Asked Questions (FAQ) :

Needle free injections are syringes which deliver drugs through direct contact with the skin instead of a hypodermic needle. They can be used by children, adults, and patients with allergic conditions without any doctor supervision. It can prevent needle stick injuries, which is a common factor of disease transmission.

The needle free injection market expanding at an astounding CAGR of 16.17% during the forecast period (2024-2032).

The needle free injection market is anticipated to reach USD 0.78 Billion by 2032, as per a new detailed report by Market Research Future (MRFR).

The key players of the global needle free injection market include MIKA MEDICAL CO., PharmaJet, Inc., PenJet Corporation, Inovio Pharmaceuticals Inc., D'Antonio Consultants International, Inc., National Medical Products Inc., Valeritas Holdings, Inc., CROSSJECT, INJEX Pharma GmBH, Endo Pharmaceuticals Inc., Antares Pharma Inc., Medical International Technology, Inc., and European Pharma Group.

Prevalence of various chronic diseases is propelling the need for needle free injections. Rise in investments in the pharmaceutical sector and convenient use of these medical devices in home care is projected to drive market growth over the forecast period.

Leading companies partner with us for data-driven Insights.

client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.